A detailed history of Wetzel Investment Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 720 shares of NVO stock, worth $91,245. This represents 0.05% of its overall portfolio holdings.

Number of Shares
720
Previous 1,080 33.33%
Holding current value
$91,245
Previous $112,000 17.86%
% of portfolio
0.05%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$102.11 - $135.92 $36,759 - $48,931
-360 Reduced 33.33%
720 $92,000
Q4 2023

Jan 31, 2024

BUY
$87.78 - $105.45 $94,802 - $113,886
1,080 New
1,080 $112,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $286B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wetzel Investment Advisors, Inc. Portfolio

Follow Wetzel Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetzel Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wetzel Investment Advisors, Inc. with notifications on news.